Secondary prevention in coronary heart disease: baseline survey of provision in general practice
- PMID: 9572757
- PMCID: PMC28543
- DOI: 10.1136/bmj.316.7142.1430
Secondary prevention in coronary heart disease: baseline survey of provision in general practice
Abstract
Objective: To determine secondary preventive treatment and habits among patients with coronary heart disease in general practice.
Design: Process of care data on a random sample of patients were collected from medical records. Health and lifestyle data were collected by postal questionnaire (response rate 71%).
Setting: Stratified, random sample of general practices in Grampian.
Subjects: 1921 patients aged under 80 years with coronary heart disease identified from pre-existing registers of coronary heart disease and nitrate prescriptions.
Main outcome measures: Treatment with aspirin, beta blockers, and angiotensin converting enzyme inhibitors. Management of lipid concentrations and hypertension according to local guidelines. Dietary habits (dietary instrument for nutritional evaluation score), physical activity (health practice indices), smoking, and body mass index.
Results: 825/1319 (63%) patients took aspirin. Of 414 patients with recent myocardial infarction, 131 (32%) took beta blockers, and of 257 with heart failure, 102 (40%) took angiotensin converting enzyme inhibitors. Blood pressure was managed according to current guidelines for 1566 (82%) patients but lipid concentrations for only 133 (17%). 673 of 1327 patients (51%) took little or no exercise, 245 of 1333 (18%) were current smokers, 808 of 1264 (64%) were overweight, and 627 of 1213 (52%) ate more fat than recommended.
Conclusion: In terms of secondary prevention, half of patients had at least two aspects of their medical management that were suboptimal and nearly two thirds had at least two aspects of their health behaviour that would benefit from change. There seems to be considerable potential to increase secondary prevention of coronary heart disease in general practice.
Comment in
-
Preventing recurrent coronary heart disease. We need to attend more to implementing evidence based practice.BMJ. 1998 May 9;316(7142):1400-1. doi: 10.1136/bmj.316.7142.1400. BMJ. 1998. PMID: 9572742 Free PMC article. No abstract available.
-
Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind.BMJ. 1998 Dec 5;317(7172):1592. doi: 10.1136/bmj.317.7172.1592. BMJ. 1998. PMID: 9836677 Free PMC article. No abstract available.
-
Secondary prevention in coronary heart disease. Payment for chronic disease management should include coronary heart disease.BMJ. 1998 Dec 5;317(7172):1592. BMJ. 1998. PMID: 9890772 No abstract available.
References
-
- NHS in Scotland Management Executive. Health promotion in primary care—a rough guide. Edinburgh: NHSME; 1996.
-
- Moher M. Evidence of effectiveness of interventions for secondary prevention and treatment of coronary heart disease in primary care. Oxford: Anglia and Oxford Regional Health Authority; 1995.
-
- Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J. 1994;15:1300–1331. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials